European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.69% to 1,746.31 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and oil and gas company Eni (E), which climbed 4.5% and 4.1% respectively. They were followed by petroleum refiner Equinor (EQNR) and telecommunications company Nokia (NOK), which advanced 2.8% and 2.2% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and lender Banco Santander (SAN), which dropped 6.5% and 3.5% respectively. They were followed by accommodations booking company trivago (TRVG) and medical device maker EDAP TMS (EDAP), which lost 2.4% each.

The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which soared 94%, followed by biopharmaceutical company Mereo BioPharma Group (MREO), which was up 3.1%. Oil and gas companies BP (BP) and Shell (SHEL) rose 1.9% and 1.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and cruise line operator Carnival (CUK), which fell 7.1% and 5.3% respectively. They were followed by biotech company Trinity Biotech (TRIB) and software firm Endava (DAVA), which were down 3% and 2.5% respectively.